Clinical Trial: NCT01441752
Efficacy Study of Integrated TCM Combined With Chemotherapy in Postoperative NSCLC Patients
Status:
COMPLETEDPhase:
Phase 3| Lead Sponsor: | xuling |
| Information Provided By: | Shanghai University of Traditional Chinese Medicine |
| Last Update Posted: | 2016-06-27 |
Study Overview
Brief Summary
The investigators performed a multi-center, randomized, controlled, double-blind, prospective study on evaluating effect of chemotherapy combined with or without integrated TCM on quality of life (QOL) of postoperative Non-small Cell Lung Cancer (NSCLC) patients. The investigators plan to involve 600 cases for observation in 3 years (300 cases for each group), expecting that QOL of postoperative NSCLC patients can be improved by integrated TCM combined with chemotherapy compared to that by chemotherapy alone.
Official Title
Conditions
Intervention / Treatment
- Drug: TCM
- Drug: placebo
Other Study ID Numbers
- LC 001
Start Date
Primary Completion Date (Actual)
Study Completion Date (Actual)
Enrollment (Actual)
Study Type
Phase
| Lead Sponsor: | xuling |
| Information Provided By: | Shanghai University of Traditional Chinese Medicine |
| Last Update Posted: | 2016-06-27 |
Study Overview
Brief Summary
The investigators performed a multi-center, randomized, controlled, double-blind, prospective study on evaluating effect of chemotherapy combined with or without integrated TCM on quality of life (QOL) of postoperative Non-small Cell Lung Cancer (NSCLC) patients. The investigators plan to involve 600 cases for observation in 3 years (300 cases for each group), expecting that QOL of postoperative NSCLC patients can be improved by integrated TCM combined with chemotherapy compared to that by chemotherapy alone.
Official Title
Conditions
Intervention / Treatment
- Drug: TCM
- Drug: placebo
Other Study ID Numbers
- LC 001